SCHEMBL3769336

SCHEMBL3769336

CN(C)CC(=O)c1cccc(-c2cc(-c3c(N4CCOCC4)sc4c3CC(C)(C)NC4=O)ccn2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 6/20 0.36
PIK3CB P42338 5/20 0.36
PIK3CG P48736 5/20 0.36
PIK3CA P42336 4/20 0.36
PLOD2 O00469 2/20 0.34
PLOD3 O60568 2/20 0.34
PLOD1 Q02809 2/20 0.34
KDM1A O60341 1/20 0.34
HDAC1 Q13547 1/20 0.34
PIK3C2A O00443 1/20 0.33
PIK3C2B O00750 1/20 0.33
ALDH1A1 P00352 1/20 0.33
ATR Q13535 1/20 0.33
ATRIP Q8WXE1 1/20 0.33
LRRK2 Q5S007 1/20 0.33
JAK2 O60674 1/20 0.33
SCN9A Q15858 1/20 0.33
JMJD6 Q6NYC1 1/20 0.32
NPSR1 Q6W5P4 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3757723 0.91 PIK3CA (0.37) PIK3CDPIK3CBPIK3CGPIK3CAPLOD2
SCHEMBL3765967 0.90 PIK3CA (0.36) PIK3CDPIK3CBPIK3CGPIK3CAPLOD2
SCHEMBL3761312 0.90 LRRK2 (0.41) PIK3CDPIK3CBPIK3CGPIK3CAPIK3C2A
SCHEMBL3765884 0.89 PRKDC (0.41) PIK3CDPIK3CBPIK3CGPIK3CAKDM1A
SCHEMBL3760006 0.89 PRKDC (0.39) PIK3CDPIK3CBPIK3CGPIK3CAKDM1A
SCHEMBL3757522 0.88 PIK3CD (0.40) PIK3CDPIK3CBPIK3CGPIK3CA
SCHEMBL3760593 0.87 PIK3CA (0.42) PIK3CDPIK3CBPIK3CGPIK3CAPIK3C2B
SCHEMBL16161804 0.87 ATR (0.40) PIK3CDPIK3CBPIK3CGPIK3CAATR
SCHEMBL3760314 0.86 PIK3CD (0.42) PIK3CDPIK3CBPIK3CGPIK3CAALDH1A1
SCHEMBL3762152 0.85 MTOR (0.38) PIK3CDPIK3CBPIK3CGPIK3CAATR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA PIK3CD 9/4885PIK3CB 11/4885PIK3CG 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.